Bio
Dr. Liebman is on the forefront of research in thrombotic and hemorrhagic disorders. His lab is currently studying the genetic risk factors responsible for thrombotic diseases including venous thrombosis, pulmonary embolism, arterial thrombosis and thrombosis associated with cancer chemotherapy. Additional studies are elucidating the role of prothrombotic defects in developing osteonecrosis. He has also been the principle investigator on a number of clinical trials in the management of immune thrombocytopenia. His research group has made important discoveries on the role of infectious agents in the development of immune thrombocytopenia. Dr. Liebman is also internationally known for his work in the relationships between venous thrombotic disease and underlying malignancy and has served on the Cancer and Thrombosis Guideline Committee of the American Society of Clinical Oncology.

Education
Doctor of Medicine, Medicine, University of Southern California, 1973
Master of Arts, Biology, Occidental College, 1969

Internships
LAC+USC Medical Center-Internal Medicine, 1973 - 1974

Residencies
LAC+USC Medical Center - Internal Medicine, 1974 - 1976

Fellowships
LAC+USC Medical Center - Oncology, 1976 - 1978
LAC+USC Medical Center - Hematology, 1978 - 1980
New England Medical Center, 1981 - 1984

Board Certification
American Board of Internal Medicine, 1976
Hematology, 1980

Professional Society Memberships
American Association for the Advancement of Science
American College of Physicians
American Federation of Clinical Research

Clinical Interests
Hemotologic malignancies
Coagulation and thrombolic disorders
AIDS
Transfusion free (bloodless medicine)
Hematology